Literature DB >> 6599540

Distinction between antiulcer effect and cytoprotection.

A Robert, C Lancaster, J P Davis, S O Field, J E Nezamis.   

Abstract

Gastric ulcerations were produced in rats by oral administration of aspirin (ASA) suspended in a vehicle consisting of either water or increasing concentrations of HCl (0.005 M to 0.35 M). The lesions were prevented by antisecretory doses of a histamine H2 blocker (cimetidine) and by an anticholinergic agent (pro-banthine), but only when the acidity of the vehicle was low (0.05 M to 0.15 M), not at higher (0.35 M). On the other hand, 16,16-dimethyl PGE2 prevented ulcer formation even when ASA was suspended in all HCl concentrations, including 0.35 M HCl. In other studies, gastric mucosal necrosis was produced by oral administration of absolute ethanol. These lesions were not affected by cimetidine or two anticholinergic agents, pro-banthine and methscopolamine bromide, nor by alkalinization of the gastric lumen with NaHCO3 or pH 7 buffer; however, these ethanol-induced lesions were completely prevented by 16,16-dimethyl PGE2. We conclude that antisecretory agents, by blocking endogenous formation of acid, are antiulcer as long as no acid or only small amounts of acid (1 ml of 0.15 M or less) are given together with ASA. When higher concentrations are used (e.g. 0.35 M HCl), the antisecretory effect of the inhibitors is overcome by the exogenous acid, and ulcers still form. Under these conditions, only "true" cytoprotective agents, such as 16,16-dimethyl PGE2, prevent ASA-induced ulcers, even in the presence of high acidity. Although cimetidine and pro-banthine were shown earlier to reduce ASA-induced ulcers at nonantisecretory doses, these agents may still decrease acid formation within the gastric glands.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6599540

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  12 in total

1.  CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective properties.

Authors:  J P Hakkinen; W F Holt; C J Goddard; P J Oates; W R Murphy; J J Maciejko; L A Reiter
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 2.  Peptic ulcer--an infectious disease?

Authors:  W L Peterson
Journal:  West J Med       Date:  1990-02

3.  Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs.

Authors:  J K Ko; C H Cho
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

4.  Gastroprotection by 4-methylpyrazole against ethanol in humans.

Authors:  G Iaquinto; M Del Tacca; L Cuccurullo; M C Parodi; N Giardullo; V D'onofrio; G Natale; D Carignani; F Ferraraccio; S Szabo
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

5.  The importance of gastric emptying and mucosal folds in the adaptive cytoprotection of mild irritants in rats.

Authors:  J K Ko; C H Cho; S K Lam; C K Ching
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

6.  Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate.

Authors:  R F Bauer; R G Bianchi; J Casler; B Goldstin
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

7.  Gastroprotective and ulcer healing profile of the mast cell stabilizer quazolast in rats.

Authors:  L R Fitzpatrick; D L Decktor
Journal:  Agents Actions       Date:  1991-07

Review 8.  Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.

Authors:  L B Katz; T Genna; G H Greeley; D A Shriver
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

9.  Possible role of sulfhydryls in mucosal protection induced by aluminum hydroxide.

Authors:  I Szelenyi; K Brune
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

10.  Direct and adaptive cytoprotection.

Authors:  E D Jacobson
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.